XTRA-INTRACRANIAL arterial bypass (EIAB) surgery was introduced successfully in patients for the first time by Donaghy, 8 and Ya~argil, et al., 27'2s in 1967 . The purpose of this operation is to provide a surgically created collateral blood supply to a hemodynamically significant ischemic cortical region. Current interest in this operation is reflected by the fact that over 500 operated cases were reported recently from over 20 clinical centers. 11,2a Although there is evidence to suggest that this operation is beneficial in the treatment of selected patients with cerebrovascular insufficiency, extraintracranial arterial bypass surgery is not yet uniformly accepted. This is mostly due to the relatively small published series of operated patients and to the difficulty in assessing the clinical usefulness of any therapeutical measure directed at the treatment of cerebral ischemia. 4 It is the purpose of this report to analyze our 5-year experience with extraintracranial bypass surgery in 65 operated patients.
Summary of Cases

Clinical Material
The series consists of 65 patients, 50 men and 15 women, ranging from 19 to 73 years of age, with a mean age of 50.1 years. Clinical data on all 65 patients is presented in Table 1 . In 56 patients the etiology of the cerebrovascular disease was considered to be hemo- ~ 0 = no deficit at examination, 1 = mild weakness of arm and leg, 2 = moderate weakness, 3 = severe weakness without useful function, 4= paralysis and spasticity preventing ambulation.
Experience with extra-intraeranial arterial anastomosis dynamic secondary to arteriosclerotic disease. 26 Of the remaining nine patients, three had local cerebral vessel obstruction secondary to brain tumor, three had traumatic internal carotid occlusions, xs'~4 two had occlusions following cardiac catheterization procedures, and in one, a middle cerebral artery occlusion occurred during surgical obliteration of an intracranial aneurysm. The classification and degree of neurological deficits are summarized in Table 2 . Risk factors associated with ischemic cerebrovascular disease are presented in Table 3 . 6,~2,~ All the women under 40 years of age among the 65 patients were taking oral contraceptives at the time of their neurological symptoms. There was an average of 3.7 attacks for each of the 10 patients presenting with transient focal cerebral ischemic attacks (TIA) prior to hospitalization. In 19 patients the diagnosis of prolonged reversible ischemic neurological deficits (PRIND) was established. These patients had a focal neurological deficit that lasted longer than 24 hours which, however, showed a tendency to clear. At the time of operation, 15 of these patients had minor neurological deficits, such as mild weakness of one extremity, subtle disorders of the sensory system, or mild aphasia. A stroke in evolution was present in seven patients, five of these revealed moderate weakness, whereas two others had severe weakness of the affected extremities. The remaining 29 patients had completed strokes; eight of these patients presented with moderate and 16 with severe weakness of the affected extremities. In the remaining five patients, neurological examination revealed severe weakness and spasticity preventing ambulation.
Preoperative Angiographic and rCBF Evaluation
Four-vessel cerebral angiography was performed in all patients (Figs. 1 to 3 ). The preoperative angiographical findings are summarized in Table 4 . In 47 of the 65 patients, preoperative rCBF studies were performed by the intra-arterial lSSXe injection method with a 16-detector apparatus. Measurements were performed with the patient under resting condition, hyperventilation and/or inhalation of CO2-in-air mixture (8%). In selected cases, autoregulation was tested as well by increasing the arterial blood pressure. For calculation of preoperative rCBF findings will be given here. Table 5 correlates rCBF findings and clinical manifestations of cerebrovascular disease in 47 patients. In Table 6 there is a corresponding correlation of preoperative rCBF findings and results of cerebral angiography (Fig. 3) .
Surgical Procedure
The operative procedure used for the EIAB is essentially unchanged from that originally reported by Donaghy, 8 and Ya~argil, et al. ~7, 28 The operation involves the dissection of the superficial temporal artery from a small temporal scalp flap. Then a small craniectomy is placed over the middle cerebral artery territory. Preoperative rCBF measurements are used to localize the ischemic area for correct placement of the bone flap. After the dura is opened, a suitable cortical artery is identified with the use of the operating microscope. The arachnoid around the vessel is removed. A rubber dam is placed under the free segment of the artery to avoid any damage of the underlying cortex. After the application of two temporary vessel clips, the superficial temporal artery is anastomosed end-to-side to the temporarily occluded segment of the cortical artery (Fig.  4) . Ten to 12 single sutures of 10/0 monofilament nylon are required. To minimize thrombotic complications, all patients received an intravenous infusion of Dextran 40 intraoperatively and for several days postoperatively . 7 In three patients, two branches of the superficial temporal artery were used as donor vessels. All patients, however, had protracted wound healing as a result of an insufficient blood supply of the temporal skin flap postoperatively. One patient with occlusions of both internal carotid arteries and ischemic cortical regions in both hemispheres had a bilateral EIAB. In two cases the posterior auricular artery was anastomosed to the middle cerebral artery (Table  7) . 54 In the patients with TIA's, the operation was performed during an asymptomatic interval. In three patients the operation was done as an emergency procedure, that is, within 4, 6, and 16 hours respectively following onset of acute cerebral ischemia. In most cases, however, an interval of 1 to 12 months elapsed between the last ischemic event and surgery (Table 8) .
Postoperative Findings
The initial evaluation of the patients postoperatively gave the following results. None of the patients in the TIA group suffered from another episode of cerebral ischemia. In the 29 patients with completed strokes no change in the clinical condition was apparent. In four out of 19 patients in the PRIND group who presented with mild hemiparesis preoperatively, neurological function returned to normal. In contrast to this, the seven patients with a stroke in evolution continued to deteriorate and three died within the first week. Clinically, these patients presented with signs of increased intracranial pressure resistant to all therapeutical measures; on postmortem examination, severe brain swelling was observed. Another two of the remaining four patients with stroke in evolution died within the first month postoperatively, one from brain edema, the other from complicating renal failure. Evaluation of the extra-intracranial anastomosis revealed graft patency in each of these fatal cases.
The most recent follow-up (October, 1974) includes observation periods from 6 to 54 months with an average of 19.2 months in 59 patients postoperatively. We did not include one patient of the completed stroke group who died 18 months postoperatively from a glioblastoma of the contralateral (nonoperated) hemisphere. When we compared the neurological condition of the operated patients at the end of the follow-up period with their preoperative neurological symp-toms (Table 9 ), we found that 25 patients belonged to the group of 19 patients with were doing well and were free of all neuro-PRIND. Postoperative improvement was logical disorders postoperatively. This in-seen in 12 patients, four from the PRIND cluded all the patients who had presented with group and eight from the completed stroke TIA's preoperatively, none of whom ex-group. In the other 20 patients with comperienced another TIA (Fig. 5) . The remain-pleted strokes, no change in the neurological ing 15 patients postoperatively asymptomatic condition was apparent. The most unsatisfac- E x p e r i e n c e with extra-intracranial arterial anastomosis tory results were in patients with stroke in evolution, with a total of 5 postoperative deaths and further progressive neurological deterioration in the other two patients.
Postoperative A ngiography and rCBF Measurements
Selective angiography 8 to 10 days postoperatively demonstrated graft patency in 41 of 43 patients. In two patients occlusion of the anastomosis was seen on angiographic films. Late follow-up angiography (2 to 28 months postoperatively), was performed in 15 patients, and a significant dilatation of the anastomosis was seen in eight. A secondary occlusion of the anastomosis was found in three cases. In one patient a stenosis of the middle cerebral artery was found on pre-and early postoperative angiography, and late follow-up arteriography revealed a complete occlusion of the previously stenosed vessel with the distal territory of the middle cerebral artery supplied by way of the anastomosis. Three patients with a patent anastomosis showed no change in the late angiographic follow-up.
A total of 40 patients underwent postoperative rCBF measurements (Table 10 ). In 33 patients the examination was carried out within 1 week after operation, the remaining patients were studied later. From a comparison of pre-and postoperative rCBF measurements, a significant increase of rCBF was found in 18 patients. In seven patients the area of increased blood flow included three measurement fields, whereas in 11 patients an even more extended area of improved blood flow was demonstrated. From selective external carotid flow studies, the function of the bypass could be ascertained in 20 patients. In two patients there was no evidence of a functioning bypass. In 15 patients two postoperative rCBF measurements were performed, with the time interval between the two studies averaging 11 months. Further improvement of rCBF was noticed in the group of patients who initially presented with TIA's and in a few patients in the PRIND group. There was no change in rCBF measurements in the patients of the completed stroke group, except for evidence of shunt obstruction in three patients. From the combined results of cerebral angiography and rCBF measurements (Table 11) had early postoperative occlusion of the bypass and three others developed secondary occlusion. In eight patients there were no postoperative data available on graft patency as neither angiography or rCBF was performed.
Postoperative Complications
The postoperative complications in our series of 65 patients are shown in Table 12 . Three patients had partial necrosis of the skin flap; in all of these cases two branches of the superficial temporal artery were anastomosed to cortical vessels. The patients with stroke in evolution continued to deteriorate after surgery, five died within the first month postoperatively. These five patients presented preoperatively as follows: two had brain tumors, one had a cerebral embolism following cardiac catheterization, one had an attempted aneurysm clipping and one had an acute occlusion of the middle cerebral artery.
Discussion
The effectiveness of any surgical endeavor is judged by its ability to favorably influence the natural history of a given disease. Thus, the merit of the EIAB procedure in the treatment of cerebral ischemia must be determined by a comparison with the natural history of cerebrovascular disease.
Five percent to 60% of patients with a history of TIA's will develop a completed stroke within a 1-year period. Over a 3-to 4-year period the incidence of stroke rises to 15% to 75%. '-8,15,~5,29 The mortality rates in TIA patients from stroke is 5% in the first year and increases to 21% over the next 4 years. 2~ These figures are in contrast to the observation that none of the 10 operated patients in the TIA group developed a permanent neurological deficit following EIAB, with the follow-up period averaging 23.1 months. Furthermore, all transient cerebral ischemic attacks stopped postoperatively as opposed to a total of 37 ischemic episodes that occurred during the preoperative period (Fig. 5) . The clinical results in this group are in agreement with findings from postoperative serial cerebral angiography and rCBF studies. There was no evidence of graft occlusion in any of the 10 patients and rCBF was normalized or significantly increased postoperatively.
It has been questioned whether a revascularization procedure should be performed in TIA patients who have generalized arteriosclerosis of the cerebral vasculature without a specific hemodynamically significant vascular lesion demonstrated angiographically. From our preoperative rCBF studies, however, there is clear evidence of a focal or relative focal ischemic region in the five patients in this category. As all these patients remained symptom-free postoperatively and rCBF studies demonstrated improved postoperative CBF, we believe that the rCBF study must be considered the decisive test in establishing the indication for an EIAB. The optimal time for surgery in patients presenting with TIA's is obviously as soon as possible, as any delay increases the risk of a subsequent stroke.
The mortality rate in the PRIND group of patients over a 4-year period varies from 17% to 40%, while up to 55% deteriorate neurologically during the same time period. 15,18 Of a total of 19 operated cases presenting with PRIND preoperatively, four patients showed neurological improvement within 8 days after surgery and none of the remaining cases deteriorated during a postoperative follow-up period of 8 to 34 months, averaging 15 months. In this group as well, a good correlation was found between the clinical course and objective data as derived from postoperative angiographic and rCBF studies. Graft patency was assessed in all patients except one. In no case was an occlusion of the anastomosis found.
Based on animal experiments, it has been suggested that EIAB might prevent neurological deficits from acute ischemia, provided reperfusion could be established within a short time after onset of symptoms? Our experience with EIAB in acute cerebral ischemia is based on three patients, where an anastomosis was performed within 4, 6 and 16 hours respectively following the occlusion of cerebral arteries. All the patients died in the early postoperative period from severe brain swelling. In the other four patients with stroke in evolution, surgery actually resulted in deterioration of the patients' clinical condition. Even though the prognosis in these patients was poor before surgery, it is our impression that EIAB at the present is contraindicated in the treatment of acute cerebral ischemia.
According to the literature, 29% to 40% of patients with completed strokes will die within 3 years from another stroke? ,~~ In our series of 29 operated patients with completed strokes, there was only one death and this was due to a glioblastoma. Furthermore, a slight improvement of neurological deficits was seen in eight patients. It should be emphasized that these eight patients had only moderate hemiparesis preoperatively and focal or relative focal disturbances on rCBF studies. Postoperative measurement of rCBF revealed an increase of cerebral perfusion in seven patients which strongly suggests a relationship between clinical improvement and improvement of rCBF.
Spontaneous recovery of neurological function after a completed stroke usually occurs within the first 7 weeks. '9 All of our cases were operated on at a much later time. From these results it is concluded that in carefully selected patients with completed strokes, it is reasonable to perform an EIAB. However, patients with severe neurological deficits or general severe reduction of CBF are poor candidates for surgery, as in this group five out of six patients revealed early (two) or late (three) occlusion of the anastomosis.
If our series is analysed temporally, some significant observations become apparent. During the first 2 years of our 5-year study, we attempted to establish proper criteria for patient selection. It was during this initial phase that the operations on acute ischemia, double anastomosis, and unselected completed stroke patients were performed. It was also during this period that all deaths, scalp necrosis, and occlusions of the anastomosis occurred. During the last 3 years, patient selection was based mainly on rCBF findings consisting of focal or relative focal ischemic areas. In this 3-year period, no morbidity or mortality was encountered. There were no shunt occlusions. The focal ischemic area, indicated by the rCBF measurements, probably represents an area of low cortical perfusion pressure, allowing a high flow through the surgically created anastomosis, which in turn diminishes the risk of occlusion. This is in contrast to the anastomosis carried out in completed strokes without a focal ischemic area, where a severe or moderate general reduction of flow is demonstrated by rCBF studies. In these patients, the cortical perfusion pressure is probably normal or near normal and allows little flow through the anastomosis, which, therefore, leads to a higher rate of occlusions. The generalized reduction of CBF is assumed to be the result from a decreased metabolic demand, secondary to the cortical damage from the old infarction. TM From our results, it is suggested that EIAB represents a promising approach in the treatment of cerebral ischemia. It appears to have a prophylactic effect against further impending cerebrovascular accidents in properly selected patients presenting with TIA's, PRIND's, and completed strokes.
